Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Revaccination With Influenza Vaccine GSK1247446A
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate an Influenza Vaccine Candidate
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV
- Status
- COMPLETED
- Phase
- PHASE3
Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4
- Status
- COMPLETED
- Phase
- PHASE4
Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
- Status
- COMPLETED
- Phase
- PHASE2
Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over
- Status
- COMPLETED
- Phase
- PHASE2
Testing a Personally Controlled Health Record to Ameliorate Influenza at MIT
- Status
- COMPLETED
- Phase
- NA
Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
- Status
- COMPLETED
- Phase
- PHASE3
Single Dose Escalating Study of DAS181 in Adults
- Status
- COMPLETED
- Phase
- PHASE1
Trial to Describe the Safety and Immunogenicity of Fluzone®
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2